(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:69112 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PMP22 mRNA CTD PMID:22079256 (20S)-20-hydroxypregn-4-en-3-one multiple interactions EXP 6480464 20-alpha-Dihydroprogesterone inhibits the reaction [docetaxel results in decreased expression of PMP22 mRNA] CTD PMID:19335538 1,2-dimethylhydrazine multiple interactions ISO RGD:11125 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PMP22 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:11125 6480464 1, 2-Dimethylhydrazine results in decreased expression of PMP22 mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of PMP22 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:69112 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PMP22 mRNA, Raloxifene Hydrochloride inhibits the reaction [Estradiol results in decreased expression of PMP22 mRNA] CTD PMID:19619570 , PMID:21185374 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PMP22 mRNA CTD PMID:32741896 17beta-estradiol decreases expression ISO RGD:69112 6480464 Estradiol results in decreased expression of PMP22 mRNA CTD PMID:19619570 more ... 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PMP22 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69112 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PMP22 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PMP22 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11125 6480464 Tetrachlorodibenzodioxin affects the expression of PMP22 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11125 6480464 Tetrachlorodibenzodioxin results in decreased expression of PMP22 mRNA CTD PMID:15328365 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69112 6480464 Tetrachlorodibenzodioxin results in decreased expression of PMP22 mRNA CTD PMID:19619570 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:32119087 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:11125 6480464 tetrabromobisphenol A results in decreased expression of PMP22 mRNA CTD PMID:25172293 3,3',5-triiodo-L-thyronine increases expression ISO RGD:11125 6480464 Triiodothyronine results in increased expression of PMP22 mRNA CTD PMID:29901742 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PMP22 mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69112 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PMP22 mRNA CTD PMID:28628672 3-Nitrobenzanthrone decreases expression ISO RGD:69112 6480464 3-nitrobenzanthrone results in decreased expression of PMP22 mRNA CTD PMID:34036453 3alpha-hydroxy-5beta-pregnan-20-one increases expression EXP 6480464 Pregnanolone results in increased expression of PMP22 mRNA CTD PMID:16787508 4,4'-sulfonyldiphenol increases expression ISO RGD:69112 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PMP22 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol decreases methylation ISO RGD:11125 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of PMP22 promoter CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:11125 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PMP22 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:11125 6480464 Fenretinide results in decreased expression of PMP22 mRNA CTD PMID:28973697 5-aminolevulinic acid decreases expression EXP 6480464 Aminolevulinic Acid results in decreased expression of PMP22 protein CTD PMID:18665889 5-aza-2'-deoxycytidine affects expression ISO RGD:69112 6480464 Decitabine affects the expression of PMP22 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine increases expression ISO RGD:69112 6480464 Decitabine results in increased expression of PMP22 mRNA CTD PMID:17785578 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PMP22 mRNA CTD PMID:24780913 afimoxifene multiple interactions ISO RGD:69112 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of PMP22 mRNA] CTD PMID:21233418 all-trans-retinoic acid increases expression ISO RGD:11125 6480464 Tretinoin results in increased expression of PMP22 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:69112 6480464 Tretinoin results in decreased expression of PMP22 mRNA CTD PMID:21934132 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PMP22 mRNA CTD PMID:16483693 arsane increases expression ISO RGD:69112 6480464 Arsenic results in increased expression of PMP22 mRNA CTD PMID:29107899 arsenic atom increases expression ISO RGD:69112 6480464 Arsenic results in increased expression of PMP22 mRNA CTD PMID:29107899 atrazine increases expression ISO RGD:69112 6480464 Atrazine results in increased expression of PMP22 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:11125 6480464 Benzo(a)pyrene results in decreased expression of PMP22 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:69112 6480464 Benzo(a)pyrene results in increased expression of PMP22 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:69112 6480464 Benzo(a)pyrene affects the methylation of PMP22 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:69112 6480464 Benzo(a)pyrene results in increased methylation of PMP22 5' UTR, Benzo(a)pyrene results in increased methylation of PMP22 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:11125 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PMP22 mRNA CTD PMID:27858113 benzo[a]pyrene affects expression ISO RGD:11125 6480464 Benzo(a)pyrene affects the expression of PMP22 mRNA CTD PMID:22342234 benzo[b]fluoranthene multiple interactions ISO RGD:11125 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PMP22 mRNA CTD PMID:27858113 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PMP22 mRNA CTD PMID:18164116 bilirubin IXalpha decreases expression ISO RGD:69112 6480464 Bilirubin results in decreased expression of PMP22 mRNA CTD PMID:20196124 bis(2-chloroethyl) sulfide decreases expression ISO RGD:11125 6480464 Mustard Gas results in decreased expression of PMP22 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate increases expression ISO RGD:69112 6480464 Diethylhexyl Phthalate results in increased expression of PMP22 mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PMP22 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:11125 6480464 bisphenol A results in increased expression of PMP22 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:69112 6480464 bisphenol A results in increased expression of PMP22 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:69112 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PMP22 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PMP22 mRNA CTD PMID:30816183 bisphenol F increases expression ISO RGD:11125 6480464 bisphenol F results in increased expression of PMP22 mRNA CTD PMID:30951980 bucladesine multiple interactions ISO RGD:11125 6480464 Ascorbic Acid inhibits the reaction [Bucladesine results in increased activity of PMP22 promoter] CTD PMID:15034573 bucladesine increases activity ISO RGD:11125 6480464 Bucladesine results in increased activity of PMP22 promoter CTD PMID:15034573 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of PMP22 mRNA CTD PMID:31077537 carbon nanotube decreases expression ISO RGD:11125 6480464 Nanotubes more ... CTD PMID:25554681 casticin increases expression ISO RGD:11125 6480464 casticin results in increased expression of PMP22 mRNA CTD PMID:28444820 choline multiple interactions ISO RGD:11125 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PMP22 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:69112 6480464 chromium hexavalent ion affects the expression of PMP22 mRNA CTD PMID:30690063 chrysene multiple interactions ISO RGD:11125 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PMP22 mRNA CTD PMID:27858113 cisplatin affects expression ISO RGD:69112 6480464 Cisplatin affects the expression of PMP22 mRNA CTD PMID:23300844 cisplatin decreases expression ISO RGD:69112 6480464 Cisplatin results in decreased expression of PMP22 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:69112 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PMP22 mRNA CTD PMID:27392435 coumestrol multiple interactions ISO RGD:69112 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of PMP22 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:69112 6480464 Cyclosporine results in decreased expression of PMP22 mRNA CTD PMID:20106945 more ... cytarabine decreases expression ISO RGD:69112 6480464 Cytarabine results in decreased expression of PMP22 mRNA CTD PMID:21198554 desferrioxamine B multiple interactions ISO RGD:69112 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of PMP22 mRNA CTD PMID:12393473 dexamethasone increases expression ISO RGD:69112 6480464 Dexamethasone results in increased expression of PMP22 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:69112 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PMP22 mRNA CTD PMID:28628672 diallyl disulfide multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of PMP22 mRNA CTD PMID:31077537 diazinon affects expression EXP 6480464 Diazinon affects the expression of PMP22 mRNA CTD PMID:22546817 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PMP22 mRNA CTD PMID:21266533 dibutyl phthalate affects expression EXP 6480464 Dibutyl Phthalate affects the expression of PMP22 mRNA CTD PMID:21745491 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of PMP22 mRNA CTD PMID:18636392 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of PMP22 mRNA CTD PMID:22546817 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PMP22 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:69112 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PMP22 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:69112 6480464 Doxorubicin results in decreased expression of PMP22 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PMP22 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:11125 6480464 epoxiconazole results in decreased expression of PMP22 mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PMP22 mRNA CTD PMID:17920746 etoposide affects response to substance ISO RGD:69112 6480464 PMP22 protein affects the susceptibility to Etoposide CTD PMID:16217747 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of PMP22 mRNA CTD PMID:30307764 ferric ammonium citrate multiple interactions ISO RGD:69112 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased expression of PMP22 mRNA CTD PMID:12393473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PMP22 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:11125 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 furan increases expression EXP 6480464 furan results in increased expression of PMP22 mRNA CTD PMID:22079235 , PMID:27387713 gallic acid decreases expression ISO RGD:69112 6480464 Gallic Acid results in decreased expression of PMP22 mRNA CTD PMID:34408198 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PMP22 mRNA CTD PMID:33387578 graphite affects expression EXP 6480464 Graphite affects the expression of PMP22 mRNA CTD PMID:29933104 hemin multiple interactions ISO RGD:69112 6480464 [Hemin results in decreased abundance of Iron] which results in increased expression of PMP22 mRNA CTD PMID:12393473 hydrogen peroxide affects expression ISO RGD:69112 6480464 Hydrogen Peroxide affects the expression of PMP22 mRNA CTD PMID:20044591 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of PMP22 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:69112 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PMP22 mRNA CTD PMID:28628672 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of PMP22 mRNA CTD PMID:20097248 iron atom increases expression ISO RGD:69112 6480464 Iron deficiency results in increased expression of PMP22 mRNA CTD PMID:20368581 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of PMP22 mRNA CTD PMID:16629162 iron atom multiple interactions ISO RGD:69112 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of PMP22 mRNA more ... CTD PMID:12393473 iron(0) multiple interactions ISO RGD:69112 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of PMP22 mRNA more ... CTD PMID:12393473 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of PMP22 mRNA CTD PMID:16629162 iron(0) increases expression ISO RGD:69112 6480464 Iron deficiency results in increased expression of PMP22 mRNA CTD PMID:20368581 L-ascorbic acid decreases expression ISO RGD:69112 6480464 Ascorbic Acid results in decreased expression of PMP22 mRNA CTD PMID:15034573 , PMID:17303424 L-ascorbic acid multiple interactions ISO RGD:11125 6480464 Ascorbic Acid inhibits the reaction [Bucladesine results in increased activity of PMP22 promoter] CTD PMID:15034573 L-methionine multiple interactions ISO RGD:11125 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PMP22 mRNA CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:69112 6480464 [S-(1 more ... CTD PMID:35811015 lithium chloride increases expression ISO RGD:11125 6480464 Lithium Chloride results in increased expression of PMP22 mRNA, Lithium Chloride results in increased expression of PMP22 protein CTD PMID:27788593 lithium chloride multiple interactions ISO RGD:11125 6480464 Lithium Chloride inhibits the reaction [Paraquat results in decreased expression of PMP22 mRNA], Lithium Chloride inhibits the reaction [Paraquat results in decreased expression of PMP22 protein] CTD PMID:27788593 mitomycin C affects response to substance ISO RGD:69112 6480464 PMP22 protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-butyl-N-(4-hydroxybutyl)nitrosamine multiple interactions ISO RGD:11125 6480464 Butylhydroxybutylnitrosamine results in decreased expression of and results in decreased localization of PMP22 protein, Niacinamide inhibits the reaction [Butylhydroxybutylnitrosamine results in decreased expression of and results in decreased localization of PMP22 protein] CTD PMID:22028816 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:11125 6480464 Ethylnitrosourea results in increased mutagenesis of PMP22 gene CTD PMID:16724327 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PMP22 mRNA CTD PMID:18164116 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of PMP22 mRNA CTD PMID:22546817 nicotinamide multiple interactions ISO RGD:11125 6480464 Niacinamide inhibits the reaction [Butylhydroxybutylnitrosamine results in decreased expression of and results in decreased localization of PMP22 protein] CTD PMID:22028816 nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of PMP22 mRNA CTD PMID:12102619 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of PMP22 mRNA CTD PMID:23358140 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of PMP22 mRNA CTD PMID:23665939 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PMP22 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PMP22 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of PMP22 mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:11125 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PMP22 mRNA CTD PMID:34911549 paclitaxel decreases response to substance ISO RGD:69112 6480464 PMP22 mRNA results in decreased susceptibility to Paclitaxel CTD PMID:16322897 paracetamol affects expression ISO RGD:11125 6480464 Acetaminophen affects the expression of PMP22 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PMP22 mRNA CTD PMID:33387578 paraquat affects expression ISO RGD:11125 6480464 Paraquat affects the expression of PMP22 mRNA CTD PMID:27788593 paraquat multiple interactions ISO RGD:11125 6480464 Lithium Chloride inhibits the reaction [Paraquat results in decreased expression of PMP22 mRNA] more ... CTD PMID:27788593 paraquat decreases expression ISO RGD:11125 6480464 Paraquat results in decreased expression of PMP22 protein CTD PMID:27788593 phenobarbital affects expression ISO RGD:69112 6480464 Phenobarbital affects the expression of PMP22 mRNA CTD PMID:19159669 pirinixic acid multiple interactions ISO RGD:69112 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PMP22 mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO RGD:69112 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PMP22 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:69112 6480464 potassium chromate(VI) results in increased expression of PMP22 mRNA CTD PMID:22714537 potassium chromate decreases expression ISO RGD:69112 6480464 potassium chromate(VI) results in decreased expression of PMP22 mRNA CTD PMID:22079256 progesterone multiple interactions EXP 6480464 Progesterone inhibits the reaction [Streptozocin results in decreased expression of PMP22 mRNA] CTD PMID:17187935 progesterone increases expression EXP 6480464 Progesterone results in increased expression of PMP22 mRNA CTD PMID:16787508 quercetin decreases expression ISO RGD:69112 6480464 Quercetin results in decreased expression of PMP22 mRNA CTD PMID:21632981 raloxifene multiple interactions ISO RGD:69112 6480464 Raloxifene Hydrochloride inhibits the reaction [Estradiol results in decreased expression of PMP22 mRNA] CTD PMID:21185374 resveratrol multiple interactions ISO RGD:69112 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of PMP22 mRNA CTD PMID:19167446 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:69112 6480464 [S-(1 more ... CTD PMID:35811015 sarin decreases expression ISO RGD:69112 6480464 Sarin results in decreased expression of PMP22 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:69112 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PMP22 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:69112 6480464 Silicon Dioxide analog results in increased expression of PMP22 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:11125 6480464 Silicon Dioxide results in increased expression of PMP22 mRNA CTD PMID:19073995 more ... sirolimus increases metabolic processing ISO RGD:11125 6480464 Sirolimus results in increased metabolism of PMP22 protein mutant form CTD PMID:20739560 sodium arsenite increases expression ISO RGD:69112 6480464 sodium arsenite results in increased expression of PMP22 protein CTD PMID:29107899 Soman increases expression EXP 6480464 Soman results in increased expression of PMP22 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 Progesterone inhibits the reaction [Streptozocin results in decreased expression of PMP22 mRNA] CTD PMID:17187935 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of PMP22 mRNA CTD PMID:17187935 sunitinib decreases expression ISO RGD:69112 6480464 Sunitinib results in decreased expression of PMP22 mRNA CTD PMID:31533062 testosterone decreases expression ISO RGD:69112 6480464 Testosterone results in decreased expression of PMP22 mRNA CTD PMID:33359661 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PMP22 mRNA CTD PMID:32741896 tetrachloromethane affects expression ISO RGD:11125 6480464 Carbon Tetrachloride affects the expression of PMP22 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:11125 6480464 Carbon Tetrachloride results in increased expression of PMP22 mRNA CTD PMID:27339419 , PMID:31919559 tetraphene multiple interactions ISO RGD:11125 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PMP22 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PMP22 mRNA CTD PMID:34492290 thyroxine increases expression ISO RGD:11125 6480464 Thyroxine results in increased expression of PMP22 mRNA CTD PMID:29901742 thyroxine increases expression EXP 6480464 Thyroxine results in increased expression of PMP22 mRNA CTD PMID:29901742 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PMP22 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of PMP22 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:69112 6480464 trichostatin A results in increased expression of PMP22 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO RGD:11125 6480464 trimellitic anhydride results in decreased expression of PMP22 mRNA CTD PMID:19042947 valproic acid affects expression ISO RGD:11125 6480464 Valproic Acid affects the expression of PMP22 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:69112 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PMP22 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:69112 6480464 Valproic Acid results in increased expression of PMP22 mRNA CTD PMID:24935251 more ... valproic acid affects expression ISO RGD:69112 6480464 Valproic Acid affects the expression of PMP22 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PMP22 mRNA CTD PMID:19015723 vincristine increases response to substance ISO RGD:69112 6480464 PMP22 gene mutant form results in increased susceptibility to Vincristine CTD PMID:12427913 zinc dichloride increases expression ISO RGD:69112 6480464 zinc chloride results in increased expression of PMP22 mRNA CTD PMID:18947441